Chemical activators of Xlr3b can be understood through various cellular mechanisms that lead to its activation. Forskolin is known to activate adenylate cyclase, which catalyzes the conversion of ATP to cAMP. Elevated levels of cAMP can activate protein kinase A (PKA), which can then phosphorylate specific target proteins, including Xlr3b, leading to its activation. Similarly, Dibutyryl-cAMP, a synthetic analog of cAMP, directly activates PKA, which subsequently can activate Xlr3b through phosphorylation. The activation of Xlr3b by Ionomycin occurs via a calcium-dependent mechanism where this chemical acts as an ionophore facilitating the release of calcium from intracellular stores. Increased intracellular calcium can activate calmodulin-dependent kinase (CaMK), which in turn can phosphorylate and activate Xlr3b. Another calcium modulator, Thapsigargin, disrupts calcium homeostasis, potentially leading to the activation of CaMK and subsequent activation of Xlr3b.
Phorbol 12-myristate 13-acetate (PMA) is a potent activator of protein kinase C (PKC), which then can phosphorylate and activate Xlr3b. PKC is typically activated through diacylglycerol (DAG) produced by receptor-mediated hydrolysis of phosphatidylinositol bisphosphate (PIP2), but PMA functions as a DAG mimic. On the other hand, Bisindolylmaleimide I inhibits PKC, and its effects on the phosphorylation state can indirectly indicate the involvement of PKC in the activation of Xlr3b. Calyculin A and Okadaic Acid are inhibitors of protein phosphatases. Their inhibitory action on phosphatases like PP1 and PP2A prevents the dephosphorylation of proteins, which can lead to a sustained phosphorylation state and activation of Xlr3b. Anisomycin activates stress-activated protein kinases (SAPKs), which can also target Xlr3b for phosphorylation and activation, particularly under stress conditions. Ryanodine affects ryanodine receptors, which are intracellular calcium channels in the endoplasmic reticulum, and their modulation by Ryanodine can influence the calcium-dependent activation of Xlr3b. Lastly, Phosphatidic Acid can activate the mammalian target of rapamycin (mTOR) signaling pathway, which is involved in various phosphorylation events, and this pathway's activation can lead to the activation of Xlr3b as well. The calcium ionophore A23187 also raises intracellular calcium levels, similarly leading to the activation of calcium-dependent kinases like CaMK, which can activate Xlr3b.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Raises intracellular calcium levels, activating CaMK, which can phosphorylate and activate Xlr3b. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates PKC which can phosphorylate and thereby activate Xlr3b. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Inhibits protein phosphatases, leading to sustained phosphorylation and activation of Xlr3b. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Inhibits protein phosphatases 1 and 2A, leading to increased phosphorylation and activation of Xlr3b. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Activates SAPKs which can phosphorylate and activate Xlr3b as part of the stress response. | ||||||
Ryanodine | 15662-33-6 | sc-201523 sc-201523A | 1 mg 5 mg | $223.00 $799.00 | 19 | |
Modulates ryanodine receptors, affecting calcium release and potentially activating CaMK to activate Xlr3b. | ||||||
Phosphatidic Acid, Dipalmitoyl | 169051-60-9 | sc-201057 sc-201057B sc-201057A | 100 mg 250 mg 500 mg | $106.00 $244.00 $417.00 | ||
Can activate mTOR signaling pathways, leading to phosphorylation events that activate Xlr3b. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Analog of cAMP that activates PKA which can phosphorylate and lead to activation of Xlr3b. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Disrupts calcium homeostasis, which can lead to CaMK activation and subsequent activation of Xlr3b. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
As PKC inhibitor, it can be used to delineate PKC-mediated phosphorylation indicative of PKC's role in Xlr3b activation. | ||||||